Brigham and Women’s Hospital Therapeutics (BWH TCRS) CRS

Location	Brigham and Women’s Hospital ACTG Clinical Research Site 15 Francis Street PBBA-4 Boston, MA 02115
CRS Coordinator	Cheryl Keenan ckeenan@bwh.harvard.edu 617-732-5635
CRS Leader	Paul Sax psax@bwh.harvard.edu 617-732-8881
Studies	A5357: A Study of Long-Acting Cabotegravir Plus VRC01LS to Maintain Viral Suppression in HIV-1-Infected Adults A5369: p24CE Vaccine Study A5366: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) A5360: MINMON Study-Monitoring SOF/VEL in Treatment Naïve, Chronic HCV Participants A5332: REPRIEVE Trial A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation (HAILO)